APOL1 Apolipoprotein L1 APOLLO APOL1 Long-term Kidney Transplantation Outcomes Consortium HIPAA Health Insurance Portability and Accountability Act LD Living Donor U.S. United States. 1 Introduction Individuals with two copies of APOL1 renal risk variants face an increased risk of kidney disease [1, 2]. Case reports and retrospective analyses suggest that living donors (LDs) with high-risk genotypes may be at greater risk of chronic kidney disease after kidney donation [3-7].
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Heidi
Contact Heidi, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack